Agents under investigation for the treatment and prevention of neutropenia.

about

Emerging small molecule and biological therapeutic approaches for the treatment of autoimmunity.The CXCR4 antagonist 4F-benzoyl-TN14003 stimulates the recovery of the bone marrow after transplantation.

P2860

Q37813704-FF9F84D8-7C70-4EDD-BFF2-C3F1ABDC84E4 Q45884149-D634D207-ACBA-42A9-BC03-180639F34541

P2860

Agents under investigation for the treatment and prevention of neutropenia.

Item

http://www.wikidata.org/entity/Q36985881

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Agents under investigation for the treatment and prevention of neutropenia.

@en

type

Item

label

Agents under investigation for the treatment and prevention of neutropenia.

@en

prefLabel

Agents under investigation for the treatment and prevention of neutropenia.

@en

P1476

Agents under investigation for the treatment and prevention of neutropenia.

@en

P2093

Alissa Huston

http://www.w3.org/2001/XMLSchema#string

Gary H Lyman

http://www.w3.org/2001/XMLSchema#string

P2860

Granulocyte colony-stimulating factor receptor signaling involves the formation of a three-component complex with Lyn and Syk protein-tyrosine kinases

Expression cloning of a human granulocyte colony-stimulating factor receptor: a structural mosaic of hematopoietin receptor, immunoglobulin, and fibronectin domains

Androstenediol stimulates myelopoiesis and enhances resistance to infection in gamma-irradiated mice

Chemokines--chemotactic cytokines that mediate inflammation

Regulation of myeloid development and function by colony stimulating factors.

5-androstenediol stimulates multilineage hematopoiesis in rhesus monkeys with radiation-induced myelosuppression.

Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: comparisons and potential for use in the treatment of infections in nonneutropenic patients.

Poloxamers and poloxamines in nanoparticle engineering and experimental medicine.

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer.

Site-specific PEGylation of engineered cysteine analogues of recombinant human granulocyte-macrophage colony-stimulating factor.

P304

1831-1840

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543784.16.11.1831

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2007-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17970641

http://www.w3.org/2001/XMLSchema#string

Agents under investigation for the treatment and prevention of neutropenia.

about

P2860

P2860

Agents under investigation for the treatment and prevention of neutropenia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698